About the Panelists
Barbara Haas-Givler
Barbara Haas-Givler, MEd, BCBA, is a board-certified behavior analyst in Lewisburg, Pennsylvania. Ms. Haas-Givler has extensive experience in special education. She has served in many different capacities over the course of her career, including classroom teacher, administrator, educational consultant, behavior analyst, and research associate for clinical pharmaceutical trials.
Ms. Haas-Givler has been a long-time member of the Fragile X community. Her dedication to providing families living with Fragile X strategies for success has greatly impacted over the years. She is also a member of the NFXF Clinical Trials Committee.
Nicole Tartaglia
Nicole Tartaglia, MD, attended university and medical school at the University of Colorado. She completed her training in general pediatrics at Children’s Hospital Los Angeles, and fellowship training in developmental-behavioral pediatrics at the University of California Davis MIND Institute, where her research focused on children and adults with developmental disabilities, chromosomal abnormalities, Fragile X syndrome, and autism spectrum disorder. She also obtained her master’s in clinical investigation from the University of Colorado Graduate School.
Since 2007, Dr. Tartaglia has worked as faculty for the Colorado School of Medicine at Children’s Hospital Colorado in the Department of Pediatrics Section of Developmental Pediatrics, where she founded and directs the eXtraordinarY Kids Clinic for children and adolescents with sex chromosome disorders, and is also the director of the Denver Fragile X Clinic. In these clinics, she leads multidisciplinary teams that include medical providers, genetic counseling, psychology, speech-language therapy, occupational therapy, nursing, and social work, and collaborates extensively with community providers, therapists, and schools to provide optimal care for these special populations. She also evaluates and treats children with general developmental delays, autism spectrum disorder, ADHD, and other neurogenetic disorders.
Dr. Tartaglia has federally funded research projects evaluating natural history and outcome measures in sex chromosome disorders and Fragile X and collaborates with national networks of clinics to develop best practices for treatments of these conditions. She is also very active in clinical trials of targeted treatment medications for neurobehavioral features and developmental disabilities. Dr. Tartaglia is also a member of the NFXF’s Clinical Trials Committee.
Vicki Wilkins
Vicki Wilkins, MD, is a pediatric hospitalist at the University of Utah who specializes in provider-family communication, experience of care, and care for children with complex healthcare conditions. She has a son with Fragile X syndrome and has therefore developed a Fragile X practice and research portfolio. She trains and coaches physicians, nurses, and other healthcare providers in engaging in difficult conversations, conflict resolution, disclosure and resolution of adverse events, and shared decision-making. She is the medical director of experience of care at Primary Children’s Hospital in Salt Lake City, Utah. Dr. Wilkins is an NFXF board member and advisor.
Cora Taylor, PhD
Dr. Taylor has expertise in the diagnostic evaluation of children with a range of developmental concerns. At Geisinger, Dr. Taylor conducts research and leads the phenotypic battery selection and administration on a variety of current research protocols at Geisinger, with a focus on the phenotypic characterization of individuals with rare genetic conditions. Dr. Taylor has experience in engaging families and family-based organizations for rare genetic conditions in research through online participation that is offered internationally to interested patients and families. Prior to joining Geisinger, Dr. Taylor completed her graduate training at the University of Tennessee, and a research and clinical postdoctoral fellowship at Vanderbilt University.
Tracy Jordan, PhD
Tracy Jordan, PhD is a licensed clinical psychologist and clinical researcher at the Stanford University Center for Interdisciplinary Brain Sciences Research. Her research interests include the intersection of genetic conditions and medical illness with cognitive, affective, and social functioning in children and adolescents. Currently, she is involved with a with a major longitudinal NIH-funded study of brain development, cognition, mood, and behavior in school-aged girls diagnosed with Fragile X syndrome. She has also been involved with projects examining neurocognitive development in school-aged boys with Klinefelter syndrome and girls with Turner syndrome.